Skip to main content
Indian Journal of Hematology & Blood Transfusion logoLink to Indian Journal of Hematology & Blood Transfusion
. 2019 Jul 1;36(1):195–197. doi: 10.1007/s12288-019-01156-z

Spontaneous Retrovesical Haematoma: A New Region for Haematoma Cause of Abdominal Pain in Haemophilia

Pusem Patir 1,, Huseyin Ucar 2
PMCID: PMC7042438  PMID: 32158105

Dear Editor,

The main defect in patients with haemophilia A is impairment of the coagulation factor FVIII secretion and/or activity from the sinusoidal cells of the liver. This is due to the specific mutation in the factor VIII gene located in the X chromosome [1]. Haemophilia A is classified as severe, moderate, or mild haemophilia in the clinic based on factor VIII protein levels: Moderate haemophilia A is defined by factor VIII (FVIII) levels between 1 and 5% [2]. These classifications generally suggest that severe haemophilias have higher risk of bleeding [3]. Haemarthrosis and haematoma are the most prevalent features of the disease. In addition, moderate haemophilia may be asymptomatic and diagnosed incidentally at the time of surgery or trauma, which can result in serious complications. We present a spontaneous retrovesical haematoma that developed in a 25-year-old male patient who had moderate haemophilia A but did not show any history of severe bleeding.

A 25-year-old male patient diagnosed with moderate haemophilia A and the replacement of the factor at the time of injury or bleeding, was admitted to the emergency department with syncope and epigastric abdominal pain. The patient had no history of abdominal trauma. Physical examination revealed tenderness over the right lower quadrant of the abdomen. Laboratory results revealed anaemia (haemoglobin 9 g/dL). Ultrasonography (USG) of the abdomen revealed no abnormalities. Pelvic magnetic resonance imaging (MRI) determined a haematoma measuring approximately 7 × 6 cm in a retrovesical location (Fig. 1). FVIII was administered randomly to the patient at a dose of 25 IU/kg every 12 h for 10 days. Plasma factor VIII level monitoring could not be done during the FVIII replacement therapy. The clinical signs started to improve with FVIII treatment. The factor treatment intervals were increased during follow-up. After 3 weeks, the haematoma volume was shown to be significantly decreased on a pelvic MRI (Fig. 2). A pelvic MRI performed after 10 weeks showed no haematoma.

Fig. 1.

Fig. 1

The MRI of abdomen, showing a retrovesical haematoma at first arrival

Fig. 2.

Fig. 2

The MRI of abdomen, showing a regression in haematoma under rFVIII treatment

To our knowledge, this is the first reported cases of spontaneous retrovesical haematoma in haemophilia. The most often reported cases of retrovesical haematomas are complications occuring during gynecological [4] and urogenital surgery [5].

Diagnosis of iliopelvic pain may also be difficult in haemophilia patients. Hip haemarthrosis, iliopsosas haematoma and acute digestive tract disorder (including appendicitis or diverticulitis) should be considered as priorities in this area. However, unusual aetiologies should not be excluded. As seen in our case, USG was observed to be useless in the diagnosis of retrovesical haematomas. MRI definitely provides the best diagnostic capabilities and should be the method of choice where possible.

Factor VIII (FVIII) replacement therapy is essential in curative and preventive management of bleeding complications. Most haematomas regress with a conservative approach and factor replacement. Our case was also treated successfully with factor treatment.

In conclusion, retrovesical haematoma should be considered as one diagnosis for iliopelvic pain in haemophilia. It should also be kept in mind that haematomas may occur in atypical locations regardless of being classified as hemophilia.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Informed Consent

Informed signed written consent was taken from the patient involved.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.DiMichele D, Neufeld EJ. Hemophilia: a new approach to an old disease. Hematol Oncol Clin North Am. 1998;12(6):1315–1344. doi: 10.1016/S0889-8588(05)70054-X. [DOI] [PubMed] [Google Scholar]
  • 2.Manson W, Hemphill RR, Kempton CL. Hemophilias and von Willebrand Disease. In: Tintinalli JE, Kelen GD, Stapczynski JS, editors. Emergency medicine: a comprehensive study guide. 7. New York: McGraw-Hill; 2010. pp. 1475–1480. [Google Scholar]
  • 3.Greene WB, Mc Milan CW. Nonsurgical management of hemophilic arthropathy. Instr Course Lect. 1989;38:367–381. [PubMed] [Google Scholar]
  • 4.FDA Executive Summary (2011) Surgical mesh for the treatment of women with pelvic organ prolapse and stress urinary incontinence. In: Obstetrics and gynecology devices advisory committee meeting
  • 5.Pereira Arias JG, Gamarra Quintanilla M, et al. Complications and incidences in our first 250 robotic radical prostatectomies. Actas Urol Esp. 2010;34(5):428–439. doi: 10.1016/j.acuro.2009.12.007. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Hematology & Blood Transfusion are provided here courtesy of Springer

RESOURCES